Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic
What do the next five years have in store for the European Medicines Agency?
Dutch institutions failing to register results of clinical trials
HAI Releases Annual Report 2019
Why TRIPS flexibilities are a crucial mechanism for access to medicines
EU Must Not Miss its Chance on WHO Technology Pool
TRIPS-flexibilities in Health Crises and Beyond
To tackle COVID-19 pandemic, transparency and collaboration are vital
Ensure transparency, affordability and availability of vaccines and treatments for COVID-19, say MEPs
HAI Follows Dutch Government Advice in Response to COVID-19
Europe’s Beating Cancer Plan
Niets magisch aan medicijnprijzen
Nothing magical about medicine prices
US puts pressure on the Netherlands over compulsory licenses
A busy week at the Court of Justice of the European Union
How to measure change in EU Policy
Health Technology Assessments: will 2020 end the deadlock?
Is clinical trial transparency under threat?
REBRAND: Fact or Fiction publication
An insightful day at the EURIPID stakeholder meeting in Budapest
A Momentous Week for Access to Medicines
Dr Marg Ewen Receives the Helen Clark-JoPPP Award
No Universal Health Coverage without Universal Medicines Coverage